Charité - Universitätsmedizin Berlin account plan
Top hospital in Berlin
At a glance
Charité is Germany's largest university medical centre: 4 Berlin campuses, 3,293 beds, 25,256 staff and EUR 2,191.3 million revenue in 2025.
Charité – Universitätsmedizin Berlin is Germany's largest university medical centre, combining a maximum-care hospital, the medical faculty for research and teaching, and a translational research area (the Berlin Institute of Health in the Charité), with more than 100 clinics and institutes on 4 campuses. Patient care is paid by health insurers, while research, teaching and most investment are funded by the Land Berlin. In 2025 revenue was EUR 2,191.3 million (2024: EUR 2,046.3 million) and total income about EUR 3.1 billion including third-party funds and investment grants; the net loss narrowed to EUR 63.6 million from EUR 87.4 million. It employed 25,256 people group-wide on average in 2025 and treated 147,997 inpatient and day cases and 853,377 outpatient cases.
Business units
Krankenversorgung (clinical care)
about 68% of 2025 revenue from inpatient care (EUR 1.5 billion) plus EUR 228 million outpatientA maximum-care hospital with 3,293 beds and 83.0% occupancy, treating 147,997 inpatient and day cases and 853,377 outpatient cases in 2025, both up on 2024. It ranked 8th in Newsweek's world hospital ranking. Led on the board by Prof. Dr. Martin E. Kreis.
Deutsches Herzzentrum der Charité (DHZC)
The heart centre, whose new building on Campus Virchow-Klinikum is meant to create one of the largest and most modern heart centres in Europe; it was the largest single investment of 2025 at EUR 39.1 million.
Fakultät (research and teaching)
The medical faculty, funded by Land Berlin grants of EUR 400.3 million and third-party income, with 4 excellence clusters, 30 DFG collaborative research centres and 28 ERC grantees, and 10,199 students in 21 programmes. Led by Dean Prof. Dr. Joachim Spranger.
Translationsforschungsbereich (Berlin Institute of Health in the Charité)
The translational research area, which founded an ARC Innovation Center with the Charité in 2025 to shorten the path from idea to clinical routine. Led by Prof. Dr. Christopher Baum.
Affiliated companies and training
Affiliated companies and holdings, including the Berliner Bildungscampus für Gesundheitsberufe, which trains 824.5 FTE trainees in 11 health professions.
Strategic priorities
- Financial consolidation
- The Charité is on a consolidation course, raising clinical output while cutting costs; the 2025 loss of EUR 63.6 million beat the business plan, but the board says it will not reach a balanced result in the following financial year either.
- Epic hospital information system
- Epic Systems is to be rolled out across the whole hospital by the end of 2029, a project with a planned volume of EUR 200 million financed with the Charité's own borrowing.
- Artificial intelligence in care
- AI activities were brought together in a new Institute for Artificial Intelligence in Medicine, meant to bring AI solutions reliably into care and prove their benefit with evidence; the CEO expects agentic AI to take over part of today's human tasks.
- Cell and gene therapy
- The CEO names cell and gene therapy as the area of most importance for the Charité's innovation work, backed by the Berlin Center for Gene and Cell Therapies driven with Bayer AG.
- Prevention
- Prevention is the second innovation focus, through interaction with academic and industrial partners and centres such as the Friede Springer – Cardiovascular Prevention Center.
- Medical data
- A joint venture with Schwarz Digits is to link medical data securely as a basis for prevention, research and treatment options.
Investments and deals
- 2025 capital spending
- EUR 132 million was invested in property, plant and equipment, intangible and financial assets in 2025, mostly financed by the Land Berlin.
- New DHZC heart centre building
- The new Deutsches Herzzentrum der Charité building on Campus Virchow-Klinikum received EUR 39.1 million in 2025; its symbolic foundation stone was laid that year.
- Epic Systems roll-out
- A planned EUR 200 million hospital information system project, due across the hospital by the end of 2029; the Charité is the first German user.
- Berlin Center for Gene and Cell Therapies
- Groundbreaking took place for the centre driven with Bayer AG; research buildings Der simulierte Mensch and Berlin Center for Advanced Therapies received EUR 10.3 million in 2025.
Challenges and risks
- Continuing losses and negative equity
- The Charité lost EUR 63.6 million in 2025 and its deficit not covered by equity rose to EUR 237.4 million; personnel expenses rose EUR 106.7 million to EUR 1,660.6 million.
- Workforce demographics and labour talks
- The CEO expects about a third of the workforce to be lost over the next ten years as baby boomers retire; Verdi's relief-agreement demands would mean up to 300 additional nurses and more than EUR 20 million of extra costs.
- Cybersecurity
- A recent cyberattack took almost 140,000 contact records, and the CEO called for massive efforts to improve cybersecurity.
- Low digitalisation
- The CEO calls the Charité's degree of digitalisation in need of improvement, and the Epic award drew criticism over its cost, US base and closed system.
- Health security preparedness
- The CEO says Germany is still poorly prepared for health security threats and expects the forthcoming Health Security Act to be highly complex.
What leadership says
“We are convinced that the future health system in Germany will rely much on preventive measures”
“We try to reorganise the entire business of innovation, just taking out the hurdles”
“Es müsste massive Anstrengungen geben, um die Cybersicherheit zu verbessern”
Where a supplier can help
- Epic implementation support
- The EUR 200 million Epic roll-out due by the end of 2029 needs integration, data migration, training and clinical workflow support across all departments.
- Cybersecurity hardening
- After the cyberattack on contact records and the CEO's call for massive efforts, security monitoring, data protection and incident response suppliers have a direct opening.
- Efficiency under consolidation
- The consolidation course and rising personnel costs favour suppliers that cut material, maintenance or administrative costs or raise clinical throughput.
- Clinical AI and workforce relief
- The new AI institute and the expected loss of a third of the workforce point to demand for evidence-backed AI tools that take over routine tasks.
- Industry partnerships in cell and gene therapy
- The Charité is building new interfaces with industrial partners in cell and gene therapy and prevention, an entry point for life-science and biotech companies.
Tamtam's reading of the priorities and challenges above, not the company's own words.
Selling to companies like Charité - Universitätsmedizin Berlin?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companiesKey documents
Read in full by Tamtam; each summary links to the document itself.
- Jahresbericht 2025 (Einblicke 2025)
- Charité – Universitätsmedizin Berlin is Germany's largest university medical centre, combining a maximum-care hospital, the medical faculty (research and teaching) and a translational research area (the Berlin Institute of Health in the Charité), on 4 campuses with more than 100 clinics and institutes.
- FY2025 revenue (Umsatzerlöse) was EUR 2,191.3 million (2024: EUR 2,046.3 million); total income was about EUR 3.1 billion including third-party funds and investment grants. Inpatient areas generated EUR 1.5 billion, outpatient services EUR 228 million.
- Still loss-making but consolidating: net loss of EUR 63.6 million in 2025 versus EUR 87.4 million in 2024, better than the business plan; the board says it will not reach a balanced result in the following financial year either.
- Cost base dominated by staff: personnel expenses EUR 1.7 billion (+EUR 106.7 million), materials EUR 914.8 million (-EUR 18.9 million), other operating expenses EUR 381.2 million incl. EUR 129.6 million maintenance.
- Scale: 25,256 employees group-wide (annual average), 3,293 beds, 147,997 inpatient and day cases (2024: 143,759) and 853,377 outpatient cases in 2025; 83.0% bed occupancy.
- Research: third-party funding raised of EUR 292.5 million, 4 excellence clusters, 30 DFG collaborative research centres, 28 ERC grantees; Land Berlin consumptive grants of EUR 400.3 million.
- Investments of EUR 132 million in 2025, mostly financed by Land Berlin, led by the new Deutsches Herzzentrum der Charité building (EUR 39.1 million).
- Digital and innovation priorities: Epic Systems chosen as the future hospital information system, a new Institute for Artificial Intelligence in Medicine, the Berlin Center for Gene and Cell Therapies with Bayer AG, an ARC Innovation Center with the BIH and a joint venture with Schwarz Digits on medical data.
- Board led by CEO Prof. Dr. Heyo K. Kroemer; Astrid Lurati runs Finance and Infrastructure, Carla Eysel Personnel and Nursing, Prof. Dr. Martin E. Kreis Clinical Care.
- Charité-Chef: Gesundheitssicherheit in Deutschland immer noch am Anfang (press briefing report, Deutsches Ärzteblatt)
- At a press briefing in Berlin on 12 November 2026, CEO Heyo Kroemer said Germany is still poorly prepared for health security (terror, viruses, military threats), unlike university hospitals in Stockholm, Copenhagen and Helsinki.
- He expects the forthcoming Health Security Act (GeSiG) to be highly complex because of the separation of civilian and military structures and federalism.
- Demographics hit health care twice: about a third of the workforce will be lost in the next ten years as baby boomers retire.
- Prevention is strategic, not a threat to the hospital's business model; he cites the Friede Springer – Cardiovascular Prevention Center.
- He expects agentic AI to take over part of today's human tasks.
- The Charité is rolling out Epic Systems as its hospital information system across the house by the end of 2029, a project of a planned EUR 200 million financed with the Charité's own borrowing; it is the first German user.
- A recent cyberattack took about 140,000 contact records; Kroemer called for "massive" efforts on cybersecurity.
- Amid a strike over the Tarifvertrag Entlastung, the Charité said Verdi's demands would mean up to 300 additional nurses and more than EUR 20 million in extra costs; staff will be added in the university outpatient clinics.
- Bridging Science, Politics, and Innovation: Unlocking Biotech Future in Europe (bio:cap interview)
- In a bio:cap interview published 15 April 2026, Charité CEO Heyo K. Kroemer says medicine is in "a really special time", with rapid progress in cell and gene therapy combined with new methods such as artificial intelligence.
- He names cell and gene therapy as the most important area for the Charité's innovation work.
- Prevention is the second priority, a field "rather unconventional for academic medical centres"; he expects the future German health system to "rely much on preventive measures".
- The main obstacle to scaling innovation in Europe is money for later phases of translation and market integration, which only politics can unlock.
- The Charité is trying to "reorganise the entire business of innovation" and build new interfaces with industrial partners.
- Bringing politics together with start-ups and investors is why the Charité engaged "heavily" as a partner in bio:cap.
Questions about Charité - Universitätsmedizin Berlin
What is Charité - Universitätsmedizin Berlin?
It is Germany's largest university medical centre, combining a maximum-care hospital, a medical faculty and the Berlin Institute of Health in the Charité, with more than 100 clinics and institutes on 4 campuses.
What was the Charité's revenue in 2025?
Revenue was EUR 2,191.3 million in 2025, with total income of about EUR 3.1 billion including third-party funds and investment grants. The year closed with a net loss of EUR 63.6 million.
How many people work at the Charité?
On average 25,256 people worked across the group in 2025, 21,493 of them at the Charité itself.
Who leads the Charité?
CEO Prof. Dr. Heyo K. Kroemer chairs the board, with Astrid Lurati (Finance and Infrastructure), Carla Eysel (Personnel and Nursing), Prof. Dr. Martin E. Kreis (Clinical Care), Dean Prof. Dr. Joachim Spranger and Prof. Dr. Christopher Baum.
What are the Charité's priorities?
Financial consolidation, the Epic hospital information system, AI in care, cell and gene therapy, and prevention.
Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)